Dr. Fadi Kayali, MD
Claim this profileFlorida Cancer Specialists South / Sarah Cannon Research Institute
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
14 reported clinical trials
40 drugs studied
Area of expertise
1Lung Cancer
Stage III
Stage IV
PD-L1 positive
2Non-Small Cell Lung Cancer
Stage III
Stage IV
PD-L1 positive
Affiliated Hospitals
Clinical Trials Fadi Kayali, MD is currently running
ONC-392 vs Chemotherapy
for Lung Cancer
This trial is testing gotistobart, a new drug that helps the immune system fight advanced lung cancer in patients who haven't responded to other treatments. It works by blocking a protein that allows cancer cells to hide from the immune system.
Recruiting2 awards Phase 310 criteria
Olomorasib
for Non-Small Cell Lung Cancer
The main purpose of this study is to assess if olomorasib in combination with pembrolizumab is more effective than the pembrolizumab and placebo combination in part A in participants with resected KRAS G12C-mutant NSCLC and to assess if olomorasib in combination with durvalumab is more effective than the durvalumab and placebo combination in part B in participants with unresectable KRAS G12C-mutant non-small cell lung cancer. The study may last up to 3 years for each participant.
Recruiting1 award Phase 38 criteria
More about Fadi Kayali, MD
Clinical Trial Related5 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Fadi Kayali, MD has experience with
- Pembrolizumab
- Placebo
- Abemaciclib
- Atezolizumab
- NT-I7
- Canakinumab
Breakdown of trials Fadi Kayali, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Fadi Kayali, MD specialize in?
Fadi Kayali, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Fadi Kayali, MD currently recruiting for clinical trials?
Yes, Fadi Kayali, MD is currently recruiting for 4 clinical trials in Fort Myers Florida. If you're interested in participating, you should apply.
Are there any treatments that Fadi Kayali, MD has studied deeply?
Yes, Fadi Kayali, MD has studied treatments such as Pembrolizumab, Placebo, Abemaciclib.
What is the best way to schedule an appointment with Fadi Kayali, MD?
Apply for one of the trials that Fadi Kayali, MD is conducting.
What is the office address of Fadi Kayali, MD?
The office of Fadi Kayali, MD is located at: Florida Cancer Specialists South / Sarah Cannon Research Institute, Fort Myers, Florida 33908 United States. This is the address for their practice at the Florida Cancer Specialists South / Sarah Cannon Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.